Evidence map›Paper›PMID 41023639›Full record

ArticleBMC infectious diseases2025

Modeling sparse Rift Valley fever incidence data: a Bayesian perspective on zero-inflated self-exciting and autoregressive models.

Alexandros Angelakis, Bryan O Nyawanda, Penelope Vounatsou

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexandros AngelakisSwiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil, CH-4123, Basel-Land, Switzerland.
Bryan O NyawandaSwiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil, CH-4123, Basel-Land, Switzerland.
Penelope VounatsouSwiss Tropical and Public Health Institute, Kreuzstrasse 2, Allschwil, CH-4123, Basel-Land, Switzerland. penelope.vounatsou@swisstph.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRift Valley fever (RVF) is a mosquito-borne zoonotic disease for which predictive modeling is often hindered by sparse data, particularly the high frequency of zero counts in both human and livestock surveillance systems. While zero-inflated models are commonly used for sparse data, several temporal count modelling frameworks exist, including less common self-exciting models that assume an initial case increases the likelihood of subsequent cases.

methodsThis study compares three zero-inflated Bayesian models: the negative binomial (ZINB) with autoregressive temporal random effects, the self-exciting negative binomial (SE-NB) and the generalized autoregressive moving average negative binomial (GARMA-NB). The models were evaluated across simulated datasets with varying levels of sparsity.

resultsWe found that zero-inflation substantially improves predictive performance within specific sparsity thresholds: 29-94.5% (ZINB), 25-93% (SE-NB), and 30-95% (GARMA-NB). Applied to monthly RVF incidence data from northern Kenya (2018-2024), the ZINB model with a three-month rainfall lag provided the most accurate forecasts.

conclusionThese findings underscore the importance of zero-inflated negative binomial models and climate-based covariates in enhancing early warning systems for RVF-endemic regions.

Indexed as

Epidemiological ModelsModels, StatisticalRift Valley FeverAnimalsBayes TheoremHumansIncidenceKenyaLivestockRift Valley fever virusBayesian inferenceGeneralized autoregressive moving average (GARMA)Negative binomialSelf-exciting processSurveillanceTime seriesZero-inflation

Identifiers

PMID41023639
PMCPMC12481985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.